SENNA Syrup
Microbial Contamination of Non-Sterile Product
Most common reason: Microbial contamination (10 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Sennosides. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Microbial Contamination of Non-Sterile Product
Subpotent Drug: Formulated amount of sennosides component is less than labelled claim.
Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported
Failed Impurities/Degradation Specifications: Atypical odor and unpleasant taste was reported
CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.
CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.
CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.
CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample.
Labeling: Label Mix-Up: Customer complaint received that a bottle labeled as Senna Laxative contained only tablets of Naproxen Sodium 220 mg.
Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
Labeling: Label Mixup: SENNOSIDES, Tablet, 8.6 mg may have potentially been mislabeled as one of the following drugs: FEXOFENADINE HCL, Tablet, 180 mg, NDC 41167412003, Pedigree: AD62834_1, EXP: 5/23/2014; TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: W002976, EXP: 6/11/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W003253, EXP: 6/17/2014.
Labeling:Label Mixup; SENNOSIDES Tablet, 8.6 mg may be potentially mislabeled as SACCHAROMYCES BOULARDII LYO, Capsule, 250 mg, NDC 00414200007, Pedigree: AD37063_7, EXP: 5/13/2014.
Subpotent (Single Ingredient) Drug: This product is being recalled because of sub-potency of the sennosides.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.